
Treating hypoactive sexual desire disorder means matching therapy to each contributing factor, according to Holly N. Thomas, MD, MS.
Take a quick look at everything you may have missed during Q1 of 2025, including the latest FDA approvals, top stories, and exclusive interviews.
As we enter the second quarter of 2025, Q1 brought key regulatory updates and clinical trial findings that impact the care of women across all stages of life.





